Prescription strategy of antimalarials in cutaneous and systemic lupus erythematosus: an international survey.

ABSTRACT:

Background

Antimalarial agents (AMs), mainly hydroxychloroquine (HCQ) and chloroquine, are the cornerstone of treatment of cutaneous and systemic lupus erythematosus. However, many aspects of AM prescription remain empirical. The aim of this study was to assess the modalities of AM prescription among physicians treating patients with lupus and to verify the assumption that AM use is heterogeneous and frequently at variance with international guidelines.

Methods

We performed an international cross-sectional study among physicians involved in lupus care, using a web-based survey (from September 2019 to July 2020) addressing the main controversial aspects of AM prescription.

Results

A total of 298 physicians [median age: 42 (interquartile range: 17) years, mainly interni

SUBMITTER: Petitdemange A 

PROVIDER: S-EPMC8138289 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature